EP2234486A4 - Benzimidazole und analoge als rho-kinasehemmer - Google Patents

Benzimidazole und analoge als rho-kinasehemmer

Info

Publication number
EP2234486A4
EP2234486A4 EP08860865A EP08860865A EP2234486A4 EP 2234486 A4 EP2234486 A4 EP 2234486A4 EP 08860865 A EP08860865 A EP 08860865A EP 08860865 A EP08860865 A EP 08860865A EP 2234486 A4 EP2234486 A4 EP 2234486A4
Authority
EP
European Patent Office
Prior art keywords
benzimidazoles
analogs
kinase inhibitors
rho kinase
rho
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08860865A
Other languages
English (en)
French (fr)
Other versions
EP2234486A1 (de
Inventor
Sarwat Chowdhury
Yangbo Feng
Thomas Bannister
Philip Lograsso
Thomas Schoeter
Hampton Sessions
Lei Yao
Bo Wang
Michael P Smolinski
Yen Ting Chen
Yan Yin
Bozena Franck-Owiac-Wojtasek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of EP2234486A1 publication Critical patent/EP2234486A1/de
Publication of EP2234486A4 publication Critical patent/EP2234486A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
EP08860865A 2007-12-19 2008-12-18 Benzimidazole und analoge als rho-kinasehemmer Withdrawn EP2234486A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US849307P 2007-12-19 2007-12-19
PCT/US2008/013865 WO2009079011A1 (en) 2007-12-19 2008-12-18 Benzimidazoles and analogs as rho kinase inhibitors

Publications (2)

Publication Number Publication Date
EP2234486A1 EP2234486A1 (de) 2010-10-06
EP2234486A4 true EP2234486A4 (de) 2011-09-14

Family

ID=44279110

Family Applications (2)

Application Number Title Priority Date Filing Date
EP08863347A Withdrawn EP2234487A4 (de) 2007-12-19 2008-12-18 Anilide und analoge als rho-kinasehemmer
EP08860865A Withdrawn EP2234486A4 (de) 2007-12-19 2008-12-18 Benzimidazole und analoge als rho-kinasehemmer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP08863347A Withdrawn EP2234487A4 (de) 2007-12-19 2008-12-18 Anilide und analoge als rho-kinasehemmer

Country Status (5)

Country Link
US (1) US20110052562A1 (de)
EP (2) EP2234487A4 (de)
JP (1) JP2011507851A (de)
CA (1) CA2709883A1 (de)
WO (1) WO2009079011A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2035369E (pt) 2006-07-05 2014-09-30 Fibrotech Therapeutics Pty Ltd Compostos terapêuticos
US20110038835A1 (en) * 2007-12-21 2011-02-17 The Scripps Research Institute Anilides and analogs as rho kinase inhibitors
CA2709918A1 (en) * 2007-12-21 2009-06-25 The Scripps Research Institute Benzopyrans and analogs as rho kinase inhibitors
EP2351743A4 (de) * 2008-10-27 2012-05-09 Takeda Pharmaceutical Bicyclische verbindung
WO2010074193A1 (ja) * 2008-12-26 2010-07-01 大日本住友製薬株式会社 新規２環性複素環化合物
WO2011002520A2 (en) * 2009-07-02 2011-01-06 Angion Biomedica Corp. Small molecule inhibitors of parp activity
IN2012DN03312A (de) * 2009-10-22 2015-10-23 Fibrotech Therapeutics Pty Ltd
EA201591390A1 (ru) 2010-06-24 2016-06-30 Джилид Сайэнс, Инк. Пиразол[1,5-a]пиримидины для противовирусного лечения
JP5667934B2 (ja) * 2010-06-28 2015-02-12 大日本住友製薬株式会社 新規２環性複素環化合物からなる医薬
EP2624696B1 (de) 2010-10-06 2016-12-21 Glaxosmithkline LLC Benzimidazolderivate als pi3-kinase-hemmer
AU2012267556B9 (en) * 2011-06-09 2017-05-11 Rhizen Pharmaceuticals Sa Novel compounds as modulators of GPR-119
EP2794611B1 (de) 2011-12-22 2017-10-11 Gilead Sciences, Inc. Pyrazol-[1,5-a-]pyrimidine als viruzide
WO2013114250A1 (en) * 2012-02-03 2013-08-08 Pfizer Inc. Benziimidazole and imidazopyridine derivatives as sodium channel modulators
CN106986869A (zh) 2012-04-17 2017-07-28 吉利德科学公司 用于抗病毒治疗的化合物和方法
US9550737B2 (en) * 2012-06-11 2017-01-24 Ucb Biopharma Sprl TNF -α modulating benzimidazoles
US8859553B2 (en) * 2012-07-30 2014-10-14 Astar Biotech Llc Protein kinase inhibitors
US10208023B2 (en) 2013-03-01 2019-02-19 Mark G. DeGiacomo Heterocyclic inhibitors of the sodium channel
AU2014296184B2 (en) 2013-07-31 2017-04-27 Gilead Sciences, Inc. Syk inhibitors
US9643947B2 (en) * 2013-08-28 2017-05-09 Northwestern University 7-membered fused heterocycles and methods of their synthesis
EP3177287B1 (de) * 2014-08-08 2022-02-23 Merck Sharp & Dohme Corp. Antidiabetische bicyclische verbindungen
US10662171B2 (en) 2014-08-08 2020-05-26 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
US9586949B2 (en) 2015-02-09 2017-03-07 Incyte Corporation Aza-heteroaryl compounds as PI3K-gamma inhibitors
JP2018515623A (ja) 2015-05-18 2018-06-14 トランスレイショナル・ドラッグ・ディベロップメント・エルエルシー キナーゼ阻害剤としての複素環式化合物
JP6987746B2 (ja) * 2015-09-28 2022-01-05 ジェネンテック， インコーポレイテッド 治療用化合物及びその使用方法
MA43169B1 (fr) 2015-11-06 2022-05-31 Incyte Corp Composés héterocycliques en tant qu' inhibiteurs pi3k-gamma
AR107032A1 (es) 2015-12-09 2018-03-14 Padlock Therapeutics Inc Inhibidores bicíclicos de pad4
WO2017120194A1 (en) 2016-01-05 2017-07-13 Incyte Corporation Pyridine and pyridimine compounds as pi3k-gamma inhibitors
CN109640988A (zh) 2016-06-21 2019-04-16 X4 制药有限公司 Cxcr4抑制剂及其用途
CN109641838A (zh) * 2016-06-21 2019-04-16 X4 制药有限公司 Cxcr4抑制剂及其用途
CN116554168A (zh) 2016-06-21 2023-08-08 X4 制药有限公司 Cxcr4抑制剂及其用途
AR108875A1 (es) 2016-06-24 2018-10-03 Incyte Corp COMPUESTOS HETEROCÍCLICOS COMO INHIBIDORES DE PI3K-g
GB201617630D0 (en) 2016-10-18 2016-11-30 Cellcentric Ltd Pharmaceutical compounds
CA3082254A1 (en) 2016-11-21 2018-05-24 Translational Drug Development, Llc Heterocyclic compounds as kinase inhibitors
CA3049728A1 (en) * 2017-01-10 2018-07-19 Eth Zurich Inhibitors of g-protein-coupled receptor kinase 2 and their use
US11014873B2 (en) 2017-02-03 2021-05-25 Certa Therapeutics Pty Ltd. Anti-fibrotic compounds
WO2018165520A1 (en) 2017-03-10 2018-09-13 Vps-3, Inc. Metalloenzyme inhibitor compounds
WO2018191607A1 (en) * 2017-04-14 2018-10-18 Massachusetts Institute Of Technology Formulations, methods, and systems for treating genitourinary conditions
JOP20180094A1 (ar) 2017-10-18 2019-04-18 Hk Inno N Corp مركب حلقي غير متجانس كمثبط بروتين كيناز
LT3697789T (lt) 2017-10-18 2021-12-10 Incyte Corporation Kondensuoti imidazolo dariniai, pakeisti tretinėmis hidroksigrupėmis, kaip pi3k-gama inhibitoriai
GB201806320D0 (en) 2018-04-18 2018-05-30 Cellcentric Ltd Process
MA53561A (fr) 2018-09-05 2022-05-11 Incyte Corp Formes cristallines d'un inhibiteur de phosphoinositide 3-kinase (pi3k)
CN110903278B (zh) * 2019-12-26 2022-08-16 山东罗欣药业集团恒欣药业有限公司 一种比拉斯汀的制备方法
CN111423435B (zh) * 2020-03-30 2021-10-15 厦门大学 (1H-咪唑并[4,5-b]吡啶-6-基)吡啶衍生物及其应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0894795A1 (de) * 1997-07-30 1999-02-03 Adir Et Compagnie Benzimidazol-, Benzoxazol-, und Benzothiazolderivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen die sie enthalten
WO2000050419A1 (de) * 1999-02-24 2000-08-31 Boehringer Ingelheim Pharma Kg Substituierte bicyclische heterocyclen und deren verwendung als thrombininhibitoren
WO2009070645A1 (en) * 2007-11-29 2009-06-04 The Ohio University Research Foundation Indoles, derivatives, and analogs thereof and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US156081A (en) * 1874-10-20 Improvement in hat-ironing machines
US150833A (en) * 1874-05-12 Improvement in running-gears for vehicles
US38835A (en) * 1863-06-09 Improvement in safety-paper
US6069143A (en) * 1994-12-20 2000-05-30 Smithkline Beecham Corporation Fibrinogen receptor antagonists
CA2340952C (en) * 1998-09-10 2009-12-08 F. Hoffmann-La Roche Ag Dihydrobenzodioxine carboxamide and ketone derivatives as 5-ht4 receptor antagonists
ATE327993T1 (de) * 2000-03-16 2006-06-15 Mitsubishi Pharma Corp Amid-verbindung und deren verwendung
ES2316777T3 (es) * 2002-02-15 2009-04-16 Glaxo Group Limited Moduladores de receptores vainilloides.
GB0206861D0 (en) * 2002-03-22 2002-05-01 Glaxo Group Ltd Medicaments
AU2003288956A1 (en) * 2002-10-30 2004-06-07 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of rock and other protein kinases
US7259266B2 (en) * 2003-03-31 2007-08-21 Pharmacia Corporation Benzopyran compounds useful for treating inflammatory conditions
WO2004105757A2 (en) * 2003-05-29 2004-12-09 Schering Aktiengesellschaft Use of rho-kinase inhibitors in the treatment of aneurysm and cardiac hypertrophy
SE0301699D0 (sv) * 2003-06-10 2003-06-10 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
EP1697375A2 (de) * 2003-12-02 2006-09-06 Vertex Pharmaceuticals Incorporated Heterocyclische proteinkinaseinhibitoren und deren anwendungen
KR20080040027A (ko) * 2005-09-02 2008-05-07 아스테라스 세이야쿠 가부시키가이샤 Ｒｏｃｋ 억제제로서 아미드 유도체
AU2007249891A1 (en) * 2006-05-12 2007-11-22 Vertex Pharmaceuticals Incorporated Selective inhibitors of ROCK protein kinase and uses thereof
WO2008032027A1 (en) * 2006-09-14 2008-03-20 Astrazeneca Ab Pyrimidine derivatives
US20110038835A1 (en) * 2007-12-21 2011-02-17 The Scripps Research Institute Anilides and analogs as rho kinase inhibitors

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0894795A1 (de) * 1997-07-30 1999-02-03 Adir Et Compagnie Benzimidazol-, Benzoxazol-, und Benzothiazolderivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen die sie enthalten
WO2000050419A1 (de) * 1999-02-24 2000-08-31 Boehringer Ingelheim Pharma Kg Substituierte bicyclische heterocyclen und deren verwendung als thrombininhibitoren
WO2009070645A1 (en) * 2007-11-29 2009-06-04 The Ohio University Research Foundation Indoles, derivatives, and analogs thereof and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MAIN C A ET AL: "High throughput synthesis of diverse 2,5-disubstituted indoles using titanium carbenoids bearing boronate functionality", TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 64, no. 5, 28 January 2008 (2008-01-28), pages 901 - 914, XP025770108, ISSN: 0040-4020, [retrieved on 20071024], DOI: 10.1016/J.TET.2007.08.119 *
See also references of WO2009079011A1 *

Also Published As

Publication number Publication date
EP2234486A1 (de) 2010-10-06
WO2009079011A1 (en) 2009-06-25
CA2709883A1 (en) 2009-06-25
JP2011507851A (ja) 2011-03-10
EP2234487A4 (de) 2011-09-07
EP2234487A1 (de) 2010-10-06
US20110052562A1 (en) 2011-03-03

Similar Documents

Publication Publication Date Title
EP2234486A4 (de) Benzimidazole und analoge als rho-kinasehemmer
EP2234618A4 (de) Benzopyrane und analoga als rho-kinase-inhibitoren
HK1219950A1 (zh) 作爲激酶抑制劑的吡咯並吡啶
ZA201004942B (en) Ptrrolopyrazine kinase inhibitors
HRP20130787T1 (en) Imidazopyridazinecarbonitriles useful as kinase inhibitors
EP2406236A4 (de) Rho-kinase-hemmer
HRP20130698T1 (en) Novel phenylpyrazinones as kinase inhibitors
HK1151291A1 (en) 2-benzylpyridazinone derivatives as met kinase inhibitors
EP2346508A4 (de) Heterocyclische kinasehemmer
HK1179477A1 (en) Kinase inhibitors
IL211549A0 (en) Aminotriazolopyridines and their use as kinase inhibitors
ZA201203842B (en) Kinase inhibitors
EP2558099A4 (de) Kinase-inhibitoren
IL212755A0 (en) Pyrazinopyrazines and derivatives as kinase inhibitors
IL210573A0 (en) Compounds as kinase inhibitors
EP2222166A4 (de) Heterocyclische kinasehemmer
EP2231152A4 (de) Thienopyranone als kinasehemmer
EP2247185A4 (de) Tyrosinkinase-hemmer
EP2480076A4 (de) Imidothiazolkinaseinhibitoren
GB0914726D0 (en) Kinase inhibitors

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100717

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

RIN1 Information on inventor provided before grant (corrected)

Inventor name: FRANCK-OWIAC-WOJTASEK, BOZENA

Inventor name: YIN, YAN

Inventor name: CHEN, YEN, TING

Inventor name: MICHAEL, P

Inventor name: SMOLINSKI, MICHAEL P

Inventor name: WANG BO

Inventor name: YAO, LEI

Inventor name: SESSIONS HAMPTON

Inventor name: SCHOETER THOMAS

Inventor name: LOGRASSO PHILIP

Inventor name: BANNISTER, THOMAS

Inventor name: FENG, YANGBO

Inventor name: CHOWDHURY, SARWAT

RIN1 Information on inventor provided before grant (corrected)

Inventor name: FRANCK-OWIAC-WOJTASEK, BOZENA

Inventor name: YIN, YAN

Inventor name: CHEN, YEN, TING

Inventor name: MICHAEL, P

Inventor name: SMOLINSKI, MICHAEL P

Inventor name: WANG BO

Inventor name: YAO, LEI

Inventor name: SESSIONS HAMPTON

Inventor name: SCHOETER THOMAS

Inventor name: LOGRASSO PHILIP

Inventor name: BANNISTER, THOMAS

Inventor name: FENG, YANGBO

Inventor name: CHOWDHURY, SARWAT

RIN1 Information on inventor provided before grant (corrected)

Inventor name: FRANCK-OWIAC-WOJTASEK, BOZENA

Inventor name: YIN, YAN

Inventor name: CHEN, YEN, TING

Inventor name: SMOLINSKI, MICHAEL P

Inventor name: WANG BO

Inventor name: YAO, LEI

Inventor name: SESSIONS HAMPTON

Inventor name: SCHOETER THOMAS

Inventor name: LOGRASSO PHILIP

Inventor name: BANNISTER, THOMAS

Inventor name: FENG, YANGBO

Inventor name: CHOWDHURY, SARWAT

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20110816

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/415 20060101ALI20110809BHEP

Ipc: A01N 43/50 20060101AFI20110809BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120313